{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:16:51Z","timestamp":1791191811847,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.jsat.2010.01.006","type":"journal-article","created":{"date-parts":[[2010,2,27]],"date-time":"2010-02-27T04:41:08Z","timestamp":1267245668000},"page":"403-407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Prospective comparative assessment of buprenorphine overdose with heroin and methadone: Clinical characteristics and response to antidotal treatment"],"prefix":"10.1016","volume":"38","author":[{"given":"Bruno","family":"M\u00e9garbane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Buisine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dabor","family":"R\u00e9si\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Chevillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vicaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric J.","family":"Baud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2010.01.006_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00003088-197601030-00004","article-title":"The relationship of pharmacokinetics to pharmacological activity: Morphine, methadone and naloxone","volume":"1","author":"Berkowitz","year":"1976","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.jsat.2010.01.006_bib2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1034\/j.1399-6576.2003.00201.x","article-title":"Serious overdoses involving buprenorphine in Helsinki","volume":"47","author":"Boyd","year":"2003","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1016\/j.jsat.2010.01.006_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1476-5381.1977.tb07533.x","article-title":"The animal pharmacology of buprenorphine, an oripavine analgesic agent","volume":"60","author":"Cowan","year":"1977","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.jsat.2010.01.006_bib4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/bja\/aei145","article-title":"Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats","volume":"94","author":"Dahan","year":"2005","journal-title":"British Journal of Anaesthesia"},{"key":"10.1016\/j.jsat.2010.01.006_bib5","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/bja\/ael051","article-title":"Buprenorphine induces ceiling in respiratory depression but not in analgesia","volume":"96","author":"Dahan","year":"2006","journal-title":"British Journal of Anaesthesia"},{"key":"10.1016\/j.jsat.2010.01.006_bib6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s11920-007-0046-2","article-title":"Why buprenorphine is so successful in treating opiate addiction in France","volume":"9","author":"Fatseas","year":"2007","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.jsat.2010.01.006_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/clpt.1989.10","article-title":"Naloxone reversal of buprenorphine-induced respiratory depression","volume":"45","author":"Gal","year":"1989","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.jsat.2010.01.006_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/09595230701373834","article-title":"Mortality related to pharmacotherapies for opioid dependence: A comparative analysis of coronial records","volume":"26","author":"Gibson","year":"2007","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2010.01.006_bib9","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1360-0443.2007.02090.x","article-title":"Exposure to opioid maintenance treatment reduces long-term mortality","volume":"103","author":"Gibson","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2010.01.006_bib10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/toxsci\/62.1.148","article-title":"Lack of effect of single high doses of buprenorphine on arterial blood gases in the rat","volume":"62","author":"Gueye","year":"2001","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.jsat.2010.01.006_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/toxsci\/65.1.107","article-title":"Buprenorphine and midazolam act in combination to depress respiration in rats","volume":"65","author":"Gueye","year":"2002","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.jsat.2010.01.006_bib12","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0196-0644(96)70191-9","article-title":"Empiric use of flumazenil in comatose patients: Limited applicability of criteria to define low risk","volume":"27","author":"Gueye","year":"1996","journal-title":"Annals of Emergency Medicine"},{"key":"10.1016\/j.jsat.2010.01.006_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1081\/CLT-120002884","article-title":"Mechanism of respiratory insufficiency in pure or mixed drug-induced coma involving benzodiazepines","volume":"40","author":"Gueye","year":"2002","journal-title":"Journal of Toxicology Clinical Toxicology"},{"key":"10.1016\/j.jsat.2010.01.006_bib14","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1046\/j.1360-0443.2002.00189.x","article-title":"Trends in opiate and opioid poisonings in addicts in north-east Paris and suburbs, 1995-99","volume":"97","author":"Gueye","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2010.01.006_bib15","doi-asserted-by":"crossref","first-page":"e782","DOI":"10.1542\/peds.2007-1774","article-title":"Toxicity of buprenorphine overdoses in children","volume":"121","author":"Hayes","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jsat.2010.01.006_bib16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0196-0644(05)80933-3","article-title":"The empiric use of naloxone in patients with altered mental status: A reappraisal","volume":"20","author":"Hoffman","year":"1991","journal-title":"Annals of Emergency Medicine"},{"key":"10.1016\/j.jsat.2010.01.006_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0379-0738(01)00454-6","article-title":"Deaths involving buprenorphine: A compendium of French cases","volume":"121","author":"Kintz","year":"2001","journal-title":"Forensic Science International"},{"key":"10.1016\/j.jsat.2010.01.006_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archinte.164.3.277","article-title":"Treating opioid dependence. Growing implications for primary care","volume":"164","author":"Krantz","year":"2004","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.jsat.2010.01.006_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.forsciint.2006.03.037","article-title":"A survey of buprenorphine related deaths in Singapore","volume":"162","author":"Lai","year":"2006","journal-title":"Forensic Science International"},{"key":"10.1016\/j.jsat.2010.01.006_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1081\/CLT-100102874","article-title":"Flumazenil use in an emergency department: A survey","volume":"39","author":"Mathieu-Nolf","year":"2001","journal-title":"Journal of Toxicology Clinical Toxicology"},{"key":"10.1016\/j.jsat.2010.01.006_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2165\/00139709-200625020-00002","article-title":"Does high-dose buprenorphine cause respiratory depression? Possible mechanisms and therapeutic consequences","volume":"25","author":"M\u00e9garbane","year":"2006","journal-title":"Toxicology Reviews"},{"key":"10.1016\/j.jsat.2010.01.006_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.toxlet.2005.02.002","article-title":"Flunitrazepam does not alter cerebral distribution of buprenorphine in the rat","volume":"157","author":"M\u00e9garbane","year":"2005","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.jsat.2010.01.006_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jsat.2007.12.007","article-title":"Methadone- and buprenorphine-related ambulance attendances: A population-based indicator of adverse events","volume":"35","author":"Nielsen","year":"2008","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2010.01.006_bib24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jama.300.1.jrr80005","article-title":"A 50-year-old woman addicted to heroin: Review of treatment of heroin addiction","volume":"300","author":"O'Brien","year":"2008","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2010.01.006_bib25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.drugalcdep.2006.12.016","article-title":"Fatal overdoses and deaths by other causes in a cohort of Norwegian drug abusers\u2014A competing risk approach","volume":"89","author":"\u00d8deg\u00e5rd","year":"2007","journal-title":"Drug Alcohol Dependence"},{"key":"10.1016\/j.jsat.2010.01.006_bib26","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1360-0443.2004.00790.x","article-title":"A critical review of the causes of death among post-mortem toxicological investigations: Analysis of 34 buprenorphine-associated and 35 methadone-associated deaths","volume":"99","author":"Pirnay","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2010.01.006_bib27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/toxsci\/kfn163","article-title":"Buprenorphine alters desmethylflunitrazepam disposition and flunitrazepam toxicity in rats","volume":"106","author":"Pirnay","year":"2008","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.jsat.2010.01.006_bib28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/01.jcp.0000245561.99036.49","article-title":"One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: A nationally representative cohort study in 2694 patients","volume":"26","author":"Soyka","year":"2006","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2010.01.006_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2006-941482","article-title":"Fatal poisoning in methadone and buprenorphine treated patients\u2014Are there differences?","volume":"39","author":"Soyka","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jsat.2010.01.006_bib30","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.annemergmed.2003.11.006","article-title":"Buprenorphine: A primer for emergency physicians","volume":"43","author":"Sporer","year":"2004","journal-title":"Annals of Emergency Medicine"},{"key":"10.1016\/j.jsat.2010.01.006_bib31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/jat\/22.6.430","article-title":"Buprenorphine-related deaths among drug addicts in France: A report on 20 fatalities","volume":"22","author":"Tracqui","year":"1998","journal-title":"Journal of Analytical Toxicology"},{"key":"10.1016\/j.jsat.2010.01.006_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000542-200607000-00012","article-title":"Naloxone reversal of buprenorphine-induced respiratory depression","volume":"105","author":"van Dorp","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jsat.2010.01.006_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/14740338.6.2.125","article-title":"Naloxone treatment in opioid addiction: The risks and benefits","volume":"6","author":"van Dorp","year":"2007","journal-title":"Expert Opinion in Drug Safety"},{"key":"10.1016\/j.jsat.2010.01.006_bib34","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1176\/appi.ajp.162.8.1432","article-title":"Medication development for addictive disorders: The state of the science","volume":"162","author":"Vocci","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2010.01.006_bib35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: Ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.jsat.2010.01.006_bib36","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00003088-200746110-00004","article-title":"Mechanism-based pharmacokinetic\u2013pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone: A study in healthy volunteers","volume":"46","author":"Yassen","year":"2007","journal-title":"Clinical Pharmacokinetics"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547210000140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547210000140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:35:11Z","timestamp":1760038511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547210000140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0740547210000140"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2010.01.006","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective comparative assessment of buprenorphine overdose with heroin and methadone: Clinical characteristics and response to antidotal treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2010.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}